Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model

Radiotherapy and Oncology

Volumn 97, Issue 3, 2010, Pages 449-454

  Zhu, Jian ^a,b   Zhang, Zi Cheng ^b   Li, Bao Sheng ^a,b   Liu, Min ^b   Yin, Yong ^b   Yu, Jin Ming ^b   Luo, Li Min ^a   Shu, Hua Zhong ^a   Crevoisier, Renaud De ^c  

^a SOUTHEAST UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^c Centre Eugne Marquis   (France)

Author keywords

Acute radiation induced esophagitis; Lyman model; Non small cell lung cancer; Normal tissue complication probability; Radiation toxicity

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MODEL; CHINESE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NORMAL TISSUE COMPLICATION PROBABILITY MODEL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

ACUTE DISEASE; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ESOPHAGITIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL;

EID: 78651483075     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.09.025     Document Type: Article

References (35)

1. J. Rose, G. Rodrigues, and B. Yaremko Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy Radiother Oncol 91 2009 282 287
2. M. Chen, G.L. Jiang, and X.L. Fu The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer Lung Cancer 28 2000 11 19
3. J.D. Cox, T.F. Pajak, and S. Asbell Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials Int J Radiat Oncol Biol Phys 27 1993 493 498
4. M. Koukourakis, G. Hlouverakis, and L. Kosma The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma Int J Radiat Oncol Biol Phys 34 1996 315 322
5. Z.C. Zhang, J. Xu, and B.S. Li Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer Am J Clin Oncol 33 2010 271 275
6. A. Jackson, G.J. Kutcher, and E.D. Yorke Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation Med Phys 20 1993 613 625
7. J.T. Lyman, and A.B. Wolbarst Optimization of radiation therapy, III: a method of assessing complication probabilities from dose-volume histograms Int J Radiat Oncol Biol Phys 13 1987 103 109
8. A. Niemierko, and M. Goitein Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture Radiother Oncol 20 1991 166 176
9. G.J. Kutcher, and C. Burman Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method Int J Radiat Oncol Biol Phys 16 1989 1623 1630
10. Y. Seppenwoolde, J.V. Lebesque, and K. De Jaeger Comparing different NTCP models that predict the incidence of radiation pneumonitis Int J Radiat Oncol Biol Phys 55 2003 724 735
11. S.M. Bentzen, L.S. Constine, and J.O. Deasy Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 2010 S3 S9
12. C. Fiorino, R. Valdagni, and T. Rancati Dose-volume effects for normal tissues in external radiotherapy: pelvis Radiother Oncol 93 2009 153 167
13. S.P. Lee, M.Y. Leu, and J.B. Smathers Biologically effective dose distribution based on the linear quadratic model and its clinical relevance Int J Radiat Oncol Biol Phys 33 1995 375 389
14. H.R. Withers, H.D. Thames Jr., and L.J. Peters A new isoeffect curve for change in dose per fraction Radiother Oncol 1 1983 187 191
15. J.T. Lyman Complication probability as assessed from dose-volume histograms Radiat Res Suppl 8 1985 S9 S13
16. L.A. Dawson, D. Normolle, and J.M. Balter Analysis of radiation-induced liver disease using the Lyman NTCP model Int J Radiat Oncol Biol Phys 53 2002 810 821
17. S.A. Roberts, and J.H. Hendry The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data Radiother Oncol 29 1993 69 74
18. D. Cox, and E. Snell Analysis of binary data 1989 Chapman and Hall New York p. 79-184
19. S. Tyldesley, C. Boyd, and K. Schulze Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach Int J Radiat Oncol Biol Phys 49 2001 973 985
20. M. Langer, S.S. Morrill, and R. Lane A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities Int J Radiat Oncol Biol Phys 41 1998 451 457
21. J. Belderbos, W. Heemsbergen, and M. Hoogeman Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy Radiother Oncol 75 2005 157 164
22. J. Bradley, J.O. Deasy, and S. Bentzen Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma Int J Radiat Oncol Biol Phys 58 2004 1106 1113
23. T.H. Kim, K.H. Cho, and H.R. Pyo Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 62 2005 995 1002
24. W.B. Qiao, Y.H. Zhao, and Y.B. Zhao Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity World J Gastroenterol 11 2005 2626 2629
25. W. Sause, P. Kolesar, and S.I. Taylor Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 2000 358 364
26. A.K. Singh, M.A. Lockett, and J.D. Bradley Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 55 2003 337 341
27. M. Werner-Wasik, E. Pequignot, and D. Leeper Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy Int J Radiat Oncol Biol Phys 48 2000 689 696
28. S. Hirota, K. Tsujino, and Y. Hishikawa Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies Radiother Oncol 58 2001 273 278
29. N. Rodriguez, M. Algara, and P. Foro Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy Int J Radiat Oncol Biol Phys 73 2009 810 817
30. W.J. Curran Jr, and M. Werner-Wasik Issues in nonoperative management of locally advanced non-small-cell lung cancer Oncology (Williston Park) 12 1998 60 66
31. C. Burman, G.J. Kutcher, and B. Emami Fitting of normal tissue tolerance data to an analytic function Int J Radiat Oncol Biol Phys 21 1991 123 135
32. O. Chapet, F.M. Kong, and J.S. Lee Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer Radiother Oncol 77 2005 176 181
33. Suzuki M, Kobayashi J, Kitamura S. 800 Radiation esophagitis in the treatment for lung cancer. Abstract 8th World Conference on Lung Cancer, vol. 18; August 1997. p. P206.
34. X. Wei, H.H. Liu, and S.L. Tucker Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 100 107
35. K.L. Wu, G.Y. Chen, and Z.Y. Xu Three-dimensional conformal radiation therapy for squamous cell carcinoma of the esophagus: a prospective phase I/II study Radiother Oncol 93 2009 454 457